Skip to main content

ASA: Adjuvant Methylprednisolone Role Examined in Acute Ischemic Stroke

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 14, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 14, 2024 -- For patients with acute ischemic stroke secondary to large-vessel occlusion (LVO) undergoing endovascular thrombectomy, adjuvant low-dose methylprednisolone does not improve the degree of overall disability, according to a study published online Feb. 8 in the Journal of the American Medical Association to coincide with the annual American Stroke Association International Stroke Conference, held from Feb. 7 to 9 in Phoenix.

Qingwu Yang, M.D., Ph.D., from Army Medical University in Chongqing, China, and colleagues examined the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for acute ischemic stroke secondary to LVO in a placebo-controlled trial implemented at 82 hospitals. Eligible patients were randomly assigned to intravenous methylprednisolone at 2 mg/kg/day or placebo (839 and 841, respectively) for three days.

The researchers found that the median 90-day modified Rankin Scale score was 3 in both groups. The mortality rate was lower in the methylprednisolone group than the placebo group (23.2 versus 28.5 percent; adjusted risk ratio, 0.84), and the rate of symptomatic intracranial hemorrhage was also lower (8.6 versus 11.7 percent; adjusted risk ratio, 0.74).

"This study is therefore one of the first, to our knowledge, to provide evidence regarding the potential role of corticosteroid therapy in the setting of endovascular stroke reperfusion," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Editorial

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Prehospital Reduction in BP Does Not Improve Stroke Outcomes

MONDAY, May 20, 2024 -- For patients with acute stroke, prehospital reduction in blood pressure does not affect functional outcomes, according to a study published online May 16...

Social Determinants of Health Impact Poststroke Mortality Risk

MONDAY, May 20, 2024 -- Social determinants of health have a cumulative impact on poststroke mortality, according to a study presented at the the annual European Stroke...

Thrombectomy Linked to Better Outcomes for Acute Stroke, Large Infarct

THURSDAY, May 9, 2024 -- For patients with acute stroke and a large infarct, thrombectomy plus medical care results in better functional outcomes and lower mortality, according to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.